Home / Intelligence / Case Studies / Early Adopter Identification Engine
Client Situation
In order to plan and efficiently utilize their sales and marketing efforts, a mid-sized biopharma client wanted to identify HCPs likely to adopt their drug in the early stage of launch
Trinity’s Role
- Developed an Early Adopter Identification Engine to predict which prescribers were likely to adopt the drug in the initial launch stage
- Collaborated with internal stakeholders and downstream partners for seamless execution
- Created a customizable dashboard for HCP profiling, targeting prioritization and sales pattern identification
- Identified and segmented early adopters in different segments through and various
classification factors
- Identified and segmented early adopters in different segments through and various
Project Outcomes
- Use of the Early Adopter solution delivered double* the adoption rate compared to the control group
*Lift percentage was obtained using test control methodology implemented during the targeting process
Related Intelligence
Briefs
2024 Annual Digital Marketing Competency Report
Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 150+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a […]
Read More
Blog
Key Takeaways and Learnings from HLTH 2024
Trinity Life Sciences recently attended the HLTH 2024 conference in Las Vegas. The conference focused on “pushing boundaries to transform the next decade of health” and united stakeholders across the entire healthcare ecosystem, including life sciences professionals, providers, payers, government, healthcare policymakers, investors and more. Trinity’s Customer Engagement team participated in workshops and discussions to […]
Read More
Webinars
Generative AI in Pharma – Five Years From Now
Available On Demand
Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]
Watch Now